Brind.

Trump pressured the FDA regarding product authorization, leading to the resignation of Marty Makary.

4 reports, 4 independent Updated Aug 18
Gone quiet
Reports
4
Developments
5
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 4 independent outlets

Trump pressured the FDA regarding product authorization, leading to the resignation of Marty Makary.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Makary resigned due to vape pressure; Carter considered for FDA Commissioner.1 source
  2. Makary resigned following controversial decisions; Overton now serves as deputy director at the think tank.1 source
  3. Makary echoed concerns and Trump shared his resignation message after leading the FDA.1 source
  4. The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.Sub-event
  5. Trump pressured the FDA regarding flavored product authorization, leading to Makary's resignation.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped